Metropolis Healthcare reports 15% growth in core business revenue during Q4FY24

12 Apr 2024 Evaluate

Metropolis Healthcare has reported around 15% growth Year-on-Year (Y-o-Y) in core business revenue during fourth quarter of FY24. Its core revenue growth was driven by volume growth around 8% and Revenue Per Patient (RPP) growth at 7% YoY for Q4FY24. RPP growth was largely driven by growth in speciality tests segment, premium wellness segment and price increase. The company’s Business-to-Consumer (B2C) revenue grew at around 18% Y-o-Y for Q4FY24. Meanwhile, the company has become debt-free in Q4FY24.  

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Metropolis Health. Share Price

433.75 2.70 (0.63%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7428.40
Max Healthcare Inst 961.65
Narayana Hrudayalay 1605.65
Aster DM Healthcare 671.55
Global Health 961.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×